Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-24 @ 10:17 PM
Study NCT ID:
NCT04318535
Status:
COMPLETED
Last Update Posted:
2020-12-28
First Post:
2020-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-06
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-20
First Submit QC Date:
None
Study First Post Date:
2020-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-12-01
Results First Submit QC Date:
None
Results First Post Date:
2020-12-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-28
Last Update Post Date Type:
ACTUAL